Ask AI
ProCE Banner Series

Managing HER2 and TROP2 ADC Adverse Events: Advanced Practice Providers Case Discussions Highlighting the Critical Roles in Patient Care

Join us and explore best practices for identifying and managing adverse events (AEs) linked to HER2- and TROP2-targeted antibody–drug conjugates (ADCs) across a range of cancer types.

Please note: You MUST be registered for JADPRO Live 2025 to attend this symposium and simulcast. You may register at: https://jadprolive.com/registration/

  AAPA
  | ANCC
Who Should Attend

This activity is intended for nurse practitioners, physician associates, nurses, and other healthcare professionals who care for patients with solid tumors.

All Events

Managing HER2 and TROP2 ADC Adverse Events: Advanced Practice Providers Case Discussions Highlighting the Critical Roles in Patient Care

Upcoming Events

October

24

2025

7:30 PM - 9:00 PM Eastern Time (ET)

In-person

8:00 PM - 9:00 PM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve nurses' knowledge and competence in identifying and managing TRAEs associated with antibody-drug conjugate therapies in solid tumors.

Target Audience
This activity is intended for nurse practitioners, physician associates, nurses, and other healthcare professionals who care for patients with solid tumors.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Summarize the mechanisms of action, therapeutic targets, and clinical trial data supporting the use of ADCs in treating solid tumors to guide patient-specific treatment decisions.
  • Implement proactive monitoring and evidence-based protocols for managing ADC-related TRAEs, including early identification and appropriate intervention strategies for high-risk adverse events.
  • Design patient-centered education and interprofessional communication plans that promote timely ADC-related TRAEs recognition and encourage urgency in reporting symptoms

Accreditation

In support of improving patient care, Partners for Advancing Clinical Education (Partners) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour, including 1.0 hour of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/657115052be04.jpg

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partner policies.

Acknowledgement

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with Clinical Care Options, LLC

Partners for Advancing Clinical Education (Partners) 2025

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191